Oseni 25 MG / 15 MG Oral Tablet

RxCUI
1368430
RxNorm name
Oseni 25 MG / 15 MG Oral Tablet
Display name
Oseni 25 MG / 15 MG Oral Tablet
Full name
Oseni 25 MG / 15 MG Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:57

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
OSENIALOGLIPTIN AND PIOGLITAZONETakeda Pharmaceuticals America, Inc.4c619ed9-fe3e-4158-9938-80c6c3493d552025-02-28Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1368430

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
4c619ed9-fe3e-4158-9938-80c6c3493d55Oseni 25 MG / 15 MG Oral TabletPSN23These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 201320250228
4c619ed9-fe3e-4158-9938-80c6c3493d55Oseni 25/15 Oral TabletSY23These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 201320250228
4c619ed9-fe3e-4158-9938-80c6c3493d55Oseni 25/15 (as alogliptin benzoate 34 MG / pioglitazone hydrochloride 16.53 MG) Oral TabletSY23These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 201320250228
4c619ed9-fe3e-4158-9938-80c6c3493d55alogliptin 25 MG / pioglitazone 15 MG Oral Tablet [Oseni]SBD23These highlights do not include all the information needed to use OSENI ® safely and effectively. See full prescribing information for OSENI. OSENI (alogliptin and pioglitazone) tablets, for oral use Initial U.S. Approval: 201320250228